H5P - Hikma Pharmaceuticals PLC Ações - Preço das Ações, Propriedade Institucional, Acionistas (DB)

Hikma Pharmaceuticals PLC
DE ˙ DB
€ 18,90 ↑0.40 (2.16%)
2026-02-24
PREÇO DA AÇÃO
Estatísticas Básicas
Proprietários Institucionais 24 total, 24 long only, 0 short only, 0 long/short - change of -28.21% MRQ
Preço da Ação 18.90
Alocação Média no Portfólio 0.2765 % - change of 29.39% MRQ
Ações em Circulação shares (source: Capital IQ)
Ações Institucionais (Longas) 7,826,967 - 3.53% (ex 13D/G) - change of -0.39MM shares -4.65% MRQ
Valor Institucional (Longa) $ 204,616 USD ($1000)
Propriedade Institucional e Acionistas

Hikma Pharmaceuticals PLC (DE:H5P) tem 24 proprietários e acionistas institucionais que enviaram os formulários 13D/G ou 13F para a Comissão de Valores Mobiliários (SEC). Essas instituições possuem um total de 7,826,967 ações. Os maiores acionistas incluem JDIBX - John Hancock Disciplined Value International Fund Class A, VGTSX - Vanguard Total International Stock Index Fund Investor Shares, VTMGX - Vanguard Developed Markets Index Fund Admiral Shares, VEURX - Vanguard European Stock Index Fund Investor Shares, VEU - Vanguard FTSE All-World ex-US Index Fund ETF Shares, VIAAX - Vanguard International Dividend Appreciation Index Fund Admiral Shares, TCIEX - TIAA-CREF International Equity Index Fund Institutional Class, BIVIX - Invenomic Fund Institutional Class shares, JAJJX - International Value Trust NAV, and VT - Vanguard Total World Stock Index Fund ETF Shares .

Hikma Pharmaceuticals PLC (DB:H5P) a estrutura de propriedade institucional mostra as posições atuais na empresa por instituições e fundos, bem como as últimas mudanças no tamanho da posição. Os principais acionistas podem incluir investidores individuais, fundos mútuos, fundos de cobertura ou instituições. O Schedule 13D indica que o investidor possui (ou possuía) mais de 5% da empresa e pretende (ou pretendia) buscar ativamente uma mudança na estratégia de negócios. O Schedule 13G indica um investimento passivo de mais de 5%.

The share price as of February 24, 2026 is 18.90 / share. Previously, on February 27, 2025, the share price was 26.20 / share. This represents a decline of 27.86% over that period.

DE:H5P / Hikma Pharmaceuticals PLC Institutional Ownership
Pontuação do Sentimento do Fundo

A Pontuação do Sentimento do Fundo (anteriormente conhecida como Pontuação de Acumulação de Propriedade) identifica as ações que estão sendo mais compradas pelos fundos. É o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os maiores níveis de acumulação institucional. O modelo de pontuação utiliza uma combinação do aumento total em proprietários divulgados, as mudanças nas alocações de portfólio desses proprietários e outras métricas. O número varia de 0 a 100, com números mais altos indicando um nível maior de acumulação em relação aos seus pares, sendo 50 a média.

Frequência de Atualização: Diariamente

Veja o Explorador de Propriedade, que fornece uma lista das empresas com melhor classificação.

AI+ Ask Fintel’s AI assistant about Hikma Pharmaceuticals PLC.

Select a question to share a public post with an AI-crafted answer.

Thinking of good questions…
Arquivamentos 13F e NPORT

Detalhes sobre Formulários 13F são gratuitos. Detalhes sobre Formulários NP requerem uma assinatura premium. Linhas verdes indicam novas posições. Linhas vermelhas indicam posições fechadas. Clique no ícone de link para ver o histórico completo de transações.

Atualize para desbloquear dados premium e exportar para Excel .

Data do Arquivo Fonte Investidor Tipo Preço Médio
(Est)
Ações Δ Ações
(%)
Valor
Reportado
(US$1000)
Δ Valor
(%)
Aloc. de Portf.
(%)
2025-09-29 NP PXF - Invesco FTSE RAFI Developed Markets ex-U.S. ETF This fund is a listed as child fund of Invesco Ltd. and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 6,052 -33.13 157 -35.00
2025-09-25 NP TWAAX - Thrivent International Allocation Fund Class A 3,490 0.00 90 -2.17
2025-09-26 NP INVESCO ACTIVELY MANAGED EXCHANGE-TRADED FUND TRUST - Invesco MSCI EAFE Income Advantage ETF 1,135 12.38 29 11.54
2025-09-26 NP BIVIX - Invenomic Fund Institutional Class shares 192,381 4.76 4,990 2.70
2025-08-29 NP JVANX - International Equity Index Trust NAV 5,587 0.00 152 7.80
2025-09-25 NP VEURX - Vanguard European Stock Index Fund Investor Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 374,261 1.78 9,674 -0.73
2025-09-25 NP VEU - Vanguard FTSE All-World ex-US Index Fund ETF Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 329,833 -1.37 8,525 -3.80
2025-08-27 NP THRIVENT SERIES FUND INC - Thrivent International Index Portfolio Class A 2,253 1,026.50 61 19.61
2025-09-25 NP VT - Vanguard Total World Stock Index Fund ETF Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 104,503 0.00 2,701 -2.46
2025-09-26 NP JDIBX - John Hancock Disciplined Value International Fund Class A 2,430,364 165.51 62,818 186.55
2025-09-26 NP MSTFX - Morningstar International Equity Fund 2,228 20.69 58 18.75
2025-09-29 NP PDN - Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF This fund is a listed as child fund of Invesco Ltd. and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 9,383 117.75 243 113.16
2025-09-25 NP VIAAX - Vanguard International Dividend Appreciation Index Fund Admiral Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 278,887 6.16 7,208 3.55
2025-08-29 NP JAJDX - International Small Company Trust NAV 4,522 0.00 123 7.89
2025-08-27 NP THRIVENT SERIES FUND INC - Thrivent International Allocation Portfolio Class A 6,384 0.00 174 8.07
2025-08-27 NP BBIEX - Bridge Builder International Equity Fund 9,182 0.00 251 8.23
2025-09-26 NP NUIAX - Nuveen Santa Barbara International Dividend Growth Fund Class A This fund is a listed as child fund of Nuveen Asset Management, LLC and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 6,693 0.13 173 -2.82
2025-08-29 NP JAFVX - Strategic Equity Allocation Trust Series NAV 19,309 839.61 527 -13.20
2025-08-28 NP John Hancock Hedged Equity & Income Fund 0 -100.00 0 -100.00
2025-08-29 NP MFDX - PIMCO RAFI Dynamic Multi-Factor International Equity ETF 6,808 1,602.00 186 56.78
2025-09-25 NP VGTSX - Vanguard Total International Stock Index Fund Investor Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 2,217,877 -4.19 57,326 -6.55
2025-08-29 NP JAJJX - International Value Trust NAV 134,754 3,677
2025-08-27 NP VTMGX - Vanguard Developed Markets Index Fund Admiral Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 1,384,041 -3.36 37,769 4.39
2025-09-26 NP TCIEX - TIAA-CREF International Equity Index Fund Institutional Class 272,401 853.79 7,041 -8.31
2025-08-29 NP JAJBX - Emerging Markets Value Trust Series I 24,639 16.64 672 26.08
Other Listings
GB:HIK £ 1.652,00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista